Epitomee Medical Ltd Cash Flow Reinvestment Rate

Latest as of December 2020: 0.01x

Epitomee Medical Ltd cash flow reinvestment rate. Epitomee Medical Ltd (EPIT) has a Cash Flow Reinvestment Rate of 0.01x as of December 2020, reinvesting ILA179.29K (capex ILA179.29K ) from operating cash flow of ILA27.75 Million. Explore EPIT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

ILA179.29K

Capex + Investments

Operating Cash Flow

ILA27.75 Million

ILA

Capital Expenditures

ILA179.29K

ILA

Cash Flow Reinvestment Rate of Epitomee Medical Ltd (2020–2020)

Cash flow reinvestment rate of Epitomee Medical Ltd from 2020 to 2020. Historical reinvestment intensity for Epitomee Medical Ltd across 1 annual periods. Explore Epitomee Medical Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Epitomee Medical Ltd Cash Flow Reinvestment Rate by Year (2020–2020)

Epitomee Medical Ltd cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Epitomee Medical Ltd. For the full cash flow conversion analysis, see EPIT cash flow metrics.

Year	Reinvestment Rate	Total Reinvested (ILA)	Operating CF	Capex	YoY Change
2020	2.33x	ILA15.74 Million	ILA6.75 Million	ILA104.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow